Evgeny Mikler

Statistics

Publications

Citations

H-Index

Active since

2013

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Evgeny Mikler is an author at Dana-Farber Cancer Institute specializing in hematologic oncology, chronic lymphocytic leukemia therapy, and hematologic malignancy therapy.

Publications per year

2013–2015

Publications

Obatoclax in combination with fludarabine and rituximab is well-tolerated and shows promising clinical activity in relapsed chronic lymphocytic leukemia

Jennifer R. Brown, Bethany Tesar, Lijian Yu et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2015 · 41 citations

Medicine, Hematology, Pharmacotherapy +11

A phase I study of escalated dose subcutaneous alemtuzumab given weekly with rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma

J. R. Brown, Bradley T. Messmer, Lillian Werner et al. · Haematologica · 2013 · 14 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacotherapy +17

1–2 of 2